Table 3 Commonly prescribed antibiotics on non-COVID-19 and COVID-19 wards in Sudan, the number of patients with isolates resistant to them and how often they were prescribed as monotherapies. Resistance data taken from phenotypic ASTs
Non-COVID-19 ward | COVID-19 ward | ||||||
|---|---|---|---|---|---|---|---|
Antibiotic | Number of patients treated | Total no. patients with resistant isolates | No. times used as a monotherapy | Antibiotic | Number of patients treated | Total no. patients with resistant isolates | No times used as a monotherapy |
Ceftazidime | 35 (67%) | 29 (56%) | 6 (17%) | Gentamicin | 39 (74%) | 23 (43%) | 0 (0%) |
Vancomycin | 19 (37%) | 0 (0%) | 0 (0%) | Azithromycin | 39 (74%) | 21 (40%) | 2 (10%) |
Ceftriaxone | 14 (27%) | 24 (46%) | 0 (0%) | Ceftazidime | 12 (23%) | 37 (70%) | 2 (17%) |
Metronidazole | 13 (25%) | Not reported | 0 (0%) | Erythromycin | 7 13%) | 9 (17%) | 0 (0%) |
Ciprofloxacin | 4 (8%) | 30 (58%) | 3 (75%) | Meropenem | 3 (6%) | 14 (26%) | 0 (0%) |